Skip Nav Destination
First Edition
Research Article September 1 2025
Inferior Survival in Double Refractory Large B-cell Lymphoma Eligible for third-line CD19 CAR T-cell Therapy
Research Article August 25 2025
Application of the International Working Group MDS Molecular Taxonomy Classes to a Single Institution Cohort
Research Article August 25 2025
Final Safety and Efficacy Results from a Phase 1/2 Study of Tagraxofusp, a CD123-Targeted Therapy, for Myelofibrosis
Research Article August 25 2025
Predicting Secondary Myeloid Neoplasms in Acquired Aplastic Anemia Using Machine Learning Models
Research Article August 25 2025
Analyses of transplantation outcomes for adult patients with mixed-phenotype acute leukemia
Research Article August 19 2025
Second Malignancies among Older Patients with Classical Myeloproliferative Neoplasms Treated with Ruxolitinib
Research Article August 19 2025
Posttransplant Rituximab Exposure and Risk of PTLD in Solid Organ Transplant Recipients with EBV DNAemia
Evelyn H. Orlando,Patrick Gould,Brian Cuzzo,Maegan Ford,Yuxuan Chen,Alexander Sanjurjo,Saagar Jain,Benjamin May,Demetra Tsapepas,Rebecca J. Leeman-Neill,Govind Bhagat,Geoffrey K. Dube,Heather Morris,Selim Arcasoy,Farhana Latif,Ersilia M. DeFilippis,Mercedes Martinez,Gene Y. Im,Meaghan M. Phipps,Marcus R. Pereira,Paul K. Sue,Manuela Orjuela-Grimm,Andrew H. Lipsky,Ahmed Sawas,Ran Reshef,Barbara Pro,Hua-Jay J. Cherng,Jennifer E. Amengual
Research Article August 5 2025
Disparities in Real-World Treatment Patterns of Hypomethylating Agents Among Patients with Myelodysplastic Syndromes in the US
Research Article August 4 2025
B-cell-Specific Wwox Deletion Promotes Plasmablastic Tumor Development and Pro-Inflammatory Signatures in Myeloma Model
Research Article August 4 2025
Orally Available Decitabine Prodrug OR-2100 induces Mitotic Perturbation for The Treatment Of Double-Hit Lymphoma
Research Article August 4 2025
Hypertension in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in ALPINE: A Secondary Analysis
Brief Report August 4 2025
Neutrophil-mediated trogocytosis as a new mechanism of action of daratumumab
Brief Report August 4 2025
A single nucleotide polymorphism in the TCL1A promoter is not protective in patients with germline RUNX1-FPD
Research Article July 25 2025
Omacetaxine and venetoclax in relapsed/refractory acute myeloid leukemia or myelodysplastic syndrome with mutant RUNX1
Courtney D. DiNardo,Wei-Ying Jen,Guillermo Montalban-Bravo,Xuemei Wang,Sanam Loghavi,Sravanthi Lavu,Nicholas J. Short,Kelly Chien,Ghayas C. Issa,Naveen Pemmaraju,Musa Yilmaz,Michael Andreeff,Gautam Borthakur,Tapan M. Kadia,Naval G. Daver,Guillermo Garcia-Manero,Christopher P. Mill,Xiaoping Su,Warren Fiskus,Kapil N. Bhalla
Brief Report July 25 2025
A Prospective Study of Prophylactic Dexamethasone with Glofitamab in Relapsed/Refractory Large B-cell Lymphoma
J. Erika Haydu,Matthew M. Lei,Robert A. Redd,Jeffrey A. Barnes,Elijah P. Darnell,Ephraim P. Hochberg,P. Connor Johnson,Ronald W. Takvorian,James I. Weitzman,Elliot C. Woods,Tiffany L. Hurvitz,Courtney D. Lafranchi,Patricia Livingstone,Julia M. Lynch,Emily N. Patterson,Jack E. Malespini,Brianne M. McGree,Alexa O. Santilli,Katherine A. Thorp,Maryanne M. Sherburne,Lindsay B. Wardrop,Uvette Y. Lou,Mark N. Sorial,Catherine Cho,Josie Ford,Ronnie Nemac,Jacob D. Soumerai,Jeremy S. Abramson.
Brief Report July 25 2025
Eμ-TCL1 mice with conditional human BCL2 knock-in as novel B cell lymphoma model for studying venetoclax effects in vivo
Research Article July 25 2025
Shelter in place: Live CLL cells inside the bone marrow fibroblasts and its implication in residual disease persistence
Research Article June 30 2025
Intensive Chemotherapy vs. Venetoclax/Hypomethylating Agents for Patients Aged 60-75 with Favorable, NPM1-mutated AML
Research Article June 3 2025